Hepatology
Feature
Widespread liver disease missed in patients with T2D
New evidence showing how common fatty liver disease and fibrosis are in patients with type 2 diabetes triggers a broadened “call to action.”
Latest News
Eliminating hepatitis by 2030: HHS releases new strategic plan
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C...
From the Journals
Liver disease associated with worse COVID-19 outcomes
More than 90% of patients can develop increased levels of ALT and AST, and these elevations appear to mirror disease severity.
Guidelines
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
The recommendation defines risk groups more narrowly than the CDC, AASLD, and some research suggests risk-based screening is ineffective for...
From the Journals
Bezafibrate eased pruritus in patients with fibrosing cholangiopathies
In all, 45% of bezafibrate recipients had at least a 50% decrease in pruritus on a 10-point visual analog scale, compared with 11% of the placebo...
From the Journals
AGA Clinical Practice Update: How diet and exercise can help manage NAFLD
NAFLD affects approximately 25% of individuals worldwide, but medication, bariatric endoscopy, and surgery are reserved for only a small subset....
News
Endoscopic intragastric balloon improved NASH parameters
At 6 months, nonalcoholic fatty liver disease activity scores had improved in 18 of 20 biopsied patients (90%), with a median decrease of 3 points...
Latest News
AASLD 2020: A clinical news roundup
A panel of reviewers highlighted abstracts from the digital edition of the 2020 Liver Meeting in the annual Clinical News Debrief.
Latest News
Aspirin and statins in chronic hepatitis B: It’s complicated
Only statins showed consistent and significant dose-dependent reductions in the risk of HCC; cirrhosis dampened aspirin’s effect.
Conference Coverage
Pronounced racial differences in HBsAg loss after stopping nucleos(t)ide
Patients of White background had a nearly sixfold higher chance for functional cure of hepatitis B infection.
Conference Coverage
HCC rates slow in cities, continue to climb in rural areas
Disparities in hepatocellular carcinoma incidence rates between urban and rural areas vary by race/ethnicity.